Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these findings, a clear link has yet to be established, and much of the evidence remains ...

At the morning UFC 319 weigh-ins on Friday, former welterweight Bryan Battle weighed in at 190 pounds ahead of his 185-pound ...

"Forever" PFAS chemicals might hamper a teenager's ability to drop excess weight, even if they've undergone weight-loss ...

“From 2019 to 2024, the percentage of adult patients with a diagnosis of overweight or obesity increased 50.7 percent, and ...

Mockery, dangerous weight loss practices and long-term health impacts — “The Biggest Loser” was a TV phenomenon that shaped ...

A recent study aimed to assess evidence on the safety and complications of preoperative glucagon-like peptide-1 (GLP-1) ...

Eli Lilly will significantly increase the price of its weight-loss drug Mounjaro in the United Kingdom in a bid to bring down ...

Fit Flavors, a St. Louis-based company, is helping you achieve your weight loss goals with its new Weight Loss Meal Plan, ...

The NHS will prescribe the weight-loss jab Mounjaro to more people in response to a dramatic price increase for private ...

Discover the benefits of Japanese sweet potatoes (Satsumaimo): low GI, high fiber, and perfect for weight loss, meal prep, ...

Weight-loss interventions before IVF increased pregnancy rates and pregnancies resulting from unassisted conception in women with obesity.

Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight, potentially transforming diabetes and obesity treatment.